The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale
The Lancet Microbe · 2026
DOI: 10.1016/j.lanmic.2025.101279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026. Verfasst von Cara Adolph und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Health, University of Otago, Dunedin, New Zealand. Electronic address: cara.adolph@otago.ac.nz. Hauptthemen laut MEDLINE: Tuberculosis, Mycobacterium tuberculosis, Biological Specimen Banks, Specimen Handling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Gates Foundation, National Institutes of Health.
Abstract (Originalsprache)
Tuberculosis remains a leading cause of death, underscoring the urgent need for a new vaccine. Progress in vaccine development is hampered by incomplete understanding of how Mycobacterium tuberculosis causes infection and disease, and of protective immunity following natural infection and vaccination. Addressing these gaps requires biological samples from tuberculosis cases and contacts or healthy controls as well as from protected and unprotected vaccinated individuals. Numerous observational studies and clinical trials on tuberculosis are conducted each year, collecting and storing diverse samples-including blood derivatives, urine, sputum, saliva, and even radiographic images-from participants. In this Personal View, we suggest that pooling samples from these studies could enable the scientific community to address important and understudied research questions at an unprecedented scale. This approach could generate new insights into fundamental disease mechanisms and the requirements for an effective vaccine. We propose linking existing biorepositories from tuberculosis studies worldwide to facilitate large-scale studies and accelerate breakthroughs in tuberculosis vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for International Health, University of Otago, Dunedin, New Zealand. Electronic address: cara.adolph@otago.ac.nz.
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
- Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, and Tuberculosis Imaging Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), Nation…
- Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.
- Centre for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA; Centre for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health and Science University, Portland, OR, USA.
Förderung
- NIAID NIH HHS
- Gates Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Division of Intramural Research
Zitieren
APA
Adolph, C., Mendelsohn, S. C., Via, L. E., Martinez, L., Lindestam Arlehamn, C. S., Lewinsohn, D. M., Torrelles, J. B., & Hill, P. C. (2026). The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101279
Vancouver
Adolph C, Mendelsohn SC, Via LE, Martinez L, Lindestam Arlehamn CS, Lewinsohn DM, et al. The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale. The Lancet Microbe. 2026. doi:10.1016/j.lanmic.2025.101279
BibTeX
@article{Adolph2026,
author = {Adolph, Cara and Mendelsohn, Simon C and Via, Laura E and Martinez, Leonardo and Lindestam Arlehamn, Cecilia S and Lewinsohn, David M and Torrelles, Jordi B and Hill, Philip C},
title = {The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale},
journal = {The Lancet Microbe},
year = {2026},
doi = {10.1016/j.lanmic.2025.101279}
}
EUVIMED